Pharmaceutical websites and the communication of risk information

Journal of Health Communication

Volumn 12, Issue 1, 2007, Pages 29-39

  Davis, Joel J ^a   Cross, Emily ^a   Crowley, John ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERTIZING; ARTICLE; CLASSIFICATION; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; INTERNET; INTERPERSONAL COMMUNICATION; PATIENT EDUCATION; PRESCRIPTION; RISK ASSESSMENT; SAFETY; STANDARD; UNITED STATES;

ADVERTISING AS TOPIC; COMMUNICATION; DATA COLLECTION; DRUG INDUSTRY; HUMANS; INCIDENCE; INTERNET; PATIENT EDUCATION AS TOPIC; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; RISK ASSESSMENT; SAFETY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33847032106     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730601091326     Document Type: Article

References (19)

1. Aikin, K. J. (2003). The impact of direct-to-consumer prescription drug advertising on the physician-patient relationship. Retrieved 16 December 2005, from http://www.fda.gov/cder/ddmac/aikin/sld001.htm
2. Berndt, E. R. (2005). To inform or persuade? direct-to-consumer advertising of prescription drugs. The New England Journal of Medicine, 32(4), 325-328.
3. Davidson, J. H. (2005). Food and Drug Administration hearings on direct to consumer advertising. Retrieved 16 December 2005, from http://www.fda.gov/cder/ddmac/dtc2005/Davidson.ppt
4. Davis, J. J. (1999). Imprecise frequency descriptors and the miscomprehension of prescription drug advertising. Journal of Technical Writing & Communication, 29(2), 133-153.
5. Davis, J. J. (2000). Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised drugs. Journal of Health Communication, 5(4), 349-369.
6. Food and Drug Association (FDA). (1999). Consumer directed broadcast advertisements: Guidance for industry. Retrieved 16 December 2005, from http://www.fda.gov/cder/guidance/1804fnl.htm
7. Food and Drug Administration (FDA). (2004). Brief summary: Disclosing risk information in consumer-directed print advertisements. Retrieved 16 December 2005, from http://www.fda.gov/cder/guidance/5669dft.pdf
8. Fintor, L. (2002). Direct-to-consumer marketing: How has it fared? Journal of the National Cancer Institute, 94(5), 329-331.
9. Holtz, W. E. (1998). Consumer-directed prescription drug advertising: Effects on public health. Journal of Law and Health, 13(2), 199-218.
10. Huh, J. & Cude, B. J. (2004). Is the information "fair and balanced" in direct-to-consumer prescription drug web sites? Journal of Health Communication, 9, 529-540.
11. Kaphingst, K. & DeJong, W. (2004). The educational potential of direct-to-consumer prescription drug advertising. Health Affairs, 23(4), 143-150.
12. Manhattan Research. (2004). Ads drive consumers to pharmaceutical websites. Retrieved 16 December 2005, from http://www.manhattanresearch.com/ 304newsletter.htm
13. Manhattan Research. (2005). The top 5 consumer trends. Retrieved 16 December 2005, from http://www.manhattanresearch.com/newsroom/Press_Releases/ 11212005.aspx
14. Macias, W. & Lewis, L. S. (2003). A content analysis of direct-to-consumner prescription drug web sites. Journal of Advertising, 32(4), 43-56.
15. National Institute for Health Care Management (NIHCM). (2000). Prescription drugs and mass media advertising. Retrieved 16 December 2005, from http://www.nihcm.org/DTCbrief.pdf
16. Pharmaceutical Research Manufacturers of America. (2005). PhRMA guiding principles. Retrieved 16 December 2005, from http://www.phrma.org/ publications/policy//admin/2005-08-02.1194.pdf
17. Richardson, L. & Luchsinger, V. (2005). Direct-to-consumer advertising of pharmaceutical products: Issue analysis and direct-to-consumer promotion. The Journal of American Academy of Business, 7(2), 100-104.
18. TNS Media Intelligence. (2005). Personal data run of 10-media advertising spending. New York: TNS Media Intelligence.
19. Vigilante, W. J. & Wogalter. M. S. (2005). Assessing risk and benefit information in direct-to-consumer medication website advertising. Drug Information Journal, 39(1), 3-12.